Risk factors associated with the onset and progression of Alzheimer's disease: A systematic review of the evidence

NeuroToxicology

Volumn 61, Issue , 2017, Pages 143-187

  Hersi, Mona ^a   Irvine, Brittany ^a   Gupta, Pallavi ^a   Gomes, James ^a   Birkett, Nicholas ^a   Krewski, Daniel ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b RISK SCIENCES INTERNATIONAL   (Canada)

Author keywords

Alzheimer's disease; Dementia; Etiology; Onset; Progression; Risk factors; Systematic review

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 2; APOLIPOPROTEIN E EPSILON 4; UNCLASSIFIED DRUG; APOLIPOPROTEIN E4;

ALZHEIMER DISEASE; ARTICLE; BODY MASS; CASE CONTROL STUDY; COGNITION; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; LONGITUDINAL STUDY; MASS SCREENING; MEDITERRANEAN DIET; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; QUALITY OF LIFE; RISK FACTOR; SYSTEMATIC REVIEW; DISEASE EXACERBATION; GENETICS; META ANALYSIS; ONSET AGE;

AGE OF ONSET; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; DISEASE PROGRESSION; HUMANS; RISK FACTORS;

EID: 85018793021     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2017.03.006     Document Type: Article

References (272)

1. Abellan van Kan, G., Rolland, Y., Gillette-Guyonnet, S., Gardette, V., Annweiler, C., Beauchet, O., Andrieu, S., Vellas, B., Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohort. J. Gerontol. 67:4 (2012), 425–432.
2. Agarwal, R., Tripathi, C.B., Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis. Am. J. Alzheimer's Dis. Other Dementias 29:7 (2014), 575–582.
3. Aglukkaq, L., Alzheimer's Awareness Month: January 2011. 2011, Health Canada http://www.hc-sc.gc.ca/ahc-asc/minist/messages/_2011/2011_01_04-eng.php.
4. Aguirre, E., Woods, R.T., Spector, A., Orrell, M., Cognitive stimulation for dementia: a systematic review of the evidence of effectiveness from randomised controlled trials. Ageing Res. Rev. 12:1 (2013), 253–262.
5. Ahlbom, A., Neurodegenerative diseases and depressive symptoms in relation to EMF. Bioelectromagnetics, 2001, S132–43.
6. Ahtiluoto, S., Polvikoski, T., Peltonen, M., Solomon, A., Tuomilehto, J., Winblad, B., Sulkava, R., Kivipelto, M., Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology 75:13 (2010), 1195–1202.
7. Allan, C.L., Ebmeier, K.P., The influence of ApoE4 on clinical progression of dementia: a meta-analysis. Int. J. Geriatr. Psychiatry 26:5 (2011), 520–526.
8. Almeida, O.P., Hulse, G.K., Lawrence, D., Flicker, L., Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction 97:1 (2002), 15–28.
9. Alzheimer Society. Rising Tide: The Impact of Dementia on Canadian Society. 2010. http://www.alzheimer.ca/∼/media/Files/national/Advocacy/ASC_Rising%20Tide Executive%20Summary_Eng.ashx.
10. Amieva, H., Stoykova, R., Matharan, F., Helmer, C., Antonucci, T.C., Dartigues, J.F., What aspects of social network are protective for dementia? Not the quantity but the quality of social interactions is protective up to 15 years later. Psychosom. Med. 72:9 (2010), 905–911.
11. Annerbo, S., Wahlund, L.O., Lökk, J., The significance of thyroid-stimulating hormone and homocysteine in the development of Alzheimer's disease in mild cognitive impairment: a 6-year follow-up study. Am. J. Alzheimer's Dis. Other Dementias 21:3 (2006), 182–188.
12. Annweiler, C., Llewellyn, D.J., Beauchet, O., Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. J. Alzheimer's Dis. 33 (2013), 659–674.
13. Anstey, K.J., von Sanden, C., Salim, A., O'Kearney, R., Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am. J. Epidemiol. 166:4 (2007), 367–378.
14. Anstey, K.J., Lipnicki, D.M., Low, L.F., Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am. J. Geriatr. Psychiatry 16:5 (2008), 343–354.
15. Anstey, K.J., Mack, H.A., Cherbuin, N., Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am. J. Geriatr. Psychiatry 17:7 (2009), 542–555.
16. Anstey, K.J., Cherbuin, N., Budge, M., Young, J., Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes. Rev. 12:5 (2011), e426–37.
17. Barnes, D.E., Yaffe, K., The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 10:9 (2011), 819–828.
18. Barnes, D.E., Yaffe, K., Byers, A.L., McCormick, M., Schaefer, C., Whitmer, R.A., et al. Midlife vs. late-life depressive symptoms and risk of dementia: Differential effects for Alzheimer's disease and vascular dementia. Arch. Gen. Psychiatry 69:5 (2012), 493–498.
19. Barranco Quintana, J.L., Allam, M.F., Serrano Del Castillo, A., Fernandez-Crehuet Navajas, R., Alzheimer's disease and coffee: a quantitative review. Neurol. Res. 29:1 (2007), 91–95.
20. Bateman, R.J., Aisen, P.S., De Strooper, B., Fox, N.C., Lemere, C.A., Ringman, J.M., Salloway, S., Sperling, R.A., Windisch, M., Xiong, C., Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimer's Res.Ther., 3(1), 2011, 1.
21. Bates, M.N., Mercury amalgam dental fillings: an epidemiological assessment. Int. J. Hyg. Environ. Health 209:4 (2006), 309–316.
22. Beri, A., Sural, N., Mahajan, S.B., Non-atheroprotective effects of statins: a systematic review. Am. J. Cardiovasc. Drugs 9:6 (2009), 361–370.
23. Bertram, L., McQueen, M.B., Mullin, K., Blacker, D., Tanzi, R.E., Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39:1 (2007), 17–23.
24. Beydoun, M.A., Beydoun, H.A., Wang, Y., Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes. Rev. 9:3 (2008), 204–218.
25. Beydoun, M.A., Beydoun, H.A., Gamaldo, A.A., Teel, A., Zonderman, A.B., Wang, Y., Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health, 14, 2014, 643.
26. Biessels, G.J., Staekenborg, S., Brunner, E., Brayne, C., Scheltens, P., Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 5:1 (2006), 64–74.
27. Blasko, I., Jellinger, K., Kemmler, G., Krampla, W., Jungwirth, S., Wichart, I., Tragl, K.H., Fischer, P., Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine. Neurobiol. Aging 29:1 (2008), 1–11.
28. Blasko, I., Kemmler, G., Jungwirth, S., Wichart, I., Krampla, W., Weissgram, S., Jellinger, K., Tragl, K.H., Fischer, P., Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer's disease. Am. J. Geriatr. Psychiatry 18:11 (2010), 973–982.
29. Bottiglieri, T., Parnetti, L., Arning, E., Ortiz, T., Amici, S., Lanari, A., Gallai, V., Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia. Mech. Ageing Dev. 122:16 (2001), 2013–2023.
30. Boyle, P.A., Buchman, A.S., Barnes, L.L., Bennett, D.A., Effect of purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons. Arch. Gen. Psychiatry 67:3 (2010), 304–310.
31. Breitner, J.C., Baker, L.D., Montine, T.J., Meinert, C.L., Lyketsos, C.G., Ashe, K.H., Brandt, J., et al. Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimer's Dementia 7:4 (2011), 402–411.
32. Breteler, M.M., van Duijn, C.M., Chandra, V., Fratiglioni, L., Graves, A.B., Heyman, A., Jorm, A.F., et al. Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20:Suppl. 2 (1991), S36–S42.
33. Brinker, K., Serum Lipids and Statin Therapy in Relation to Alzheimer's Disease: Exploring the Relationship Between Elevated Serum Cholesterol Levels and Alzheimer's Disease Dementia. 2011, Diss. Cornell University.
34. Bruscoli, M., Lovestone, S., Is MCI really just early dementia? A systematic review of conversion studies. Int. Psychogeriatr. 16:2 (2004), 129–140.
35. Caamano-Isorna, F., Corral, M., Montes-Martinez, A., Takkouche, B., Education and dementia: a meta-analytic study. Neuroepidemiology 26:4 (2006), 226–232.
36. Cataldo, J.K., Prochaska, J.J., Glantz, S.A., Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation. J. Alzheimer's Disease 19:2 (2010), 465–480.
37. Chang, C.L., Obesity and alzheimer's disease. Hong Kong J. Psychiatry 18:1 (2008), 28–35.
38. Chang-Quan, H., Hui, W., Chao-Min, W., Zheng-Rong, W., Jun-Wen, G., Yong-Hong, L., Yan-You, L., Qing-Xiu, L., The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies. Int. J. Clin. Pract. 65:12 (2011), 1295–1305.
39. Chen, Y.C., Chen, T.F., Yip, P.K., Hu, C.Y., Chu, Y.M., Chen, J.H., Body mass index (BMI) at an early age and the risk of dementia. Archiv. Gerontol. Geriatrics 50:Suppl. 1 (2010), S48–S52.
40. Chen, J.J., Li, Y.M., Zou, W.Y., Fu, J.L., Relationships between CETP genetic polymorphisms and Alzheimer's disease risk: a meta-analysis. DNA Cell Biol. 33 (2014), 807–815.
41. Cheng, D., Noble, J., Tang, M.X., Schupf, N., Mayeux, R., Luchsinger, J.A., Type 2 diabetes and late-onset Alzheimer's disease. Dementia Geriatric Cognit. Disord. 31:6 (2011), 424–430.
42. Cheng, G., Huang, C., Deng, H., Wang, H., Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern. Med. J. 42 (2012), 484–491.
43. Cheng, D., Liang, B., Hao, Y., Zhou, W., Estrogen receptor alpha gene polymorphisms and risk of Alzheimer's disease: evidence from a meta-analysis. Clin. Interv. Aging 9 (2014), 1031–1038.
44. Chu, L.W., Tam, S., Wong, R.L., Yik, P.Y., Song, Y., Cheung, B.M., Morley, J.E., Lam, K.S., Bioavailable testosterone predicts a lower risk of Alzheimer's disease in older men. J. Alzheimer's Dis. 21:4 (2010), 1335–1345.
45. Clarke, R., Smith, A.D., Jobst, K.A., Refsum, H., Sutton, L., Ueland, P.M., Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 55:11 (1998), 1449–1455.
46. Cooper, C., Sommerlad, A., Lyketsos, C.G., Livingston, G., Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am. J. Psychiatry 172 (2015), 323–334.
47. Crichton, G.E., Bryan, J., Murphy, K.J., Buckley, J., Review of dairy consumption and cognitive performance in adults: findings and methodological issues. Dementia Geriatric Cognit. Disord. 30:4 (2010), 352–361.
48. Cukierman, T., Gerstein, H.C., Williamson, J.D., Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia 48:12 (2005), 2460–2469.
49. Dangour, A.D., Whitehouse, P.J., Rafferty, K., Mitchell, S.A., Smith, L., Hawkesworth, S., Vellas, B., B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review. J. Alzheimer's Dis. 22:1 (2010), 205–224.
50. Daviglus, M.L., Plassman, B.L., Pirzada, A., Bell, C.C., Bowen, P.E., Burke, J.R., Connolly, E.S. Jr., et al. Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch. Neurol. 68:9 (2011), 1185–1190.
51. Debette, S., Markus, H.S., The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ, 341, 2010, c3666.
52. Del Bo, R., Scarlato, M., Ghezzi, S., Martinelli-Boneschi, F., Fenoglio, C., Galimberti, G., Galbiati, S., et al. Is M129 V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiol. Aging, 27(5), 2006 (770. e1-770.e5).
53. Desilets, A.R., Koslowski, D.A., Dunican, K.C., The role of statins in the prevention and treatment of Alzheimer's disease. J. Pharm. Technol. 26 (2010), 276–284.
54. Devore, E.E., Grodstein, F., van Rooij, F.J., Hofman, A., Stampfer, M.J., Witteman, J.C., Breteler, M.M., Dietary antioxidants and long-term risk of dementia. Arch. Neurol. 67:7 (2010), 819–825.
55. Di Bona, D., Plaia, A., Vasto, S., Cavallone, L., Lescai, F., Franceschi, C., Licastro, F., Colonna-Romano, G., Lio, D., Candore, G., Caruso, C., Association between the interleukin-1β polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. Brain Res. Rev. 59:1 (2008), 155–163.
56. Di Bona, D., Candore, G., Franceschi, C., Licastro, F., Colonna-Romano, G., Cammà, C., Lio, D., Caruso, C., Systematic review by meta-analyses on the possible role of TNF-β polymorphisms in association with Alzheimer's disease. Brain Res. Rev. 61:2 (2009), 60–68.
57. Diniz, B.S., Pinto, J.A. Jr., Gonzaga, M.L., Guimaraes, F.M., Gattaz, W.F., Forlenza, O.V., To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease. Eur. Archi. Psychiatry Clin. Neurosci. 259:4 (2009), 248–256.
58. Diniz, B.S., Butters, M.A., Albert, S.M., Dew, M.A., Reynolds, C.F. 3rd, Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br. J. Psychiatry 202 (2013), 329–335.
59. Dotson, V.M., Beydoun, M.A., Zonderman, A.B., Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75:1 (2010), 27–34.
60. Driver, J.A., Beiser, A., Au, R., Kreger, B.E., Splansky, G.L., Kurth, T., Kiel, D.P., Lu, K.P., Seshadri, S., Wolf, P.A., Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study. BMJ, 344, 2012, e1442.
61. Dublin, S., Anderson, M.L., Haneuse, S.J., Heckbert, S.R., Crane, P.K., Breitner, J.C., McCormick, W., et al. Atrial fibrillation and risk of dementia: a prospective cohort study. J. Am. Geriatr. Soc. 59:8 (2011), 1369–1375.
62. ESHRE Capri Workshop Groupi, Perimenopausal risk factors and future health. Hum. Reprod. Update 17:5 (2011), 706–717.
63. Elias-Sonnenschein, L.S., Viechtbauer, W., Ramakers, I.H., Verhey, F.R., Visser, P.J., Predictive value of APOE-4 allele for progression from MCI to AD-type dementia: a meta-analysis Journal of Neurology. Neurosurg. Psychiatry 82:10 (2011), 1149–1156.
64. Elkins, J.S., Douglas, V.C., Johnston, S.C., Alzheimer disease risk and genetic variation in ACE: a meta-analysis. Neurology 62:3 (2004), 363–368.
65. Engelman, M., Agree, E.M., Meoni, L.A., Klag, M.J., Propositional density and cognitive function in later life: findings from the Precursors Study. J. Gerontol. Ser. B-Psychol.Sci. Soc. Sci. 65:6 (2010), 706–711.
66. Eriksson, U.K., Bennet, A.M., Gatz, M., Dickman, P.W., Pedersen, N.L., Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia. Alzheimer Dis. Assoc. Disord. 24:3 (2010), 213–219.
67. Eriksson, U.K., Sjoberg, B.G., Bennet, A.M., de Faire, U., Pedersen, N.L., Frostegard, J., Low levels of antibodies against phosphorylcholine in Alzheimer's disease. J. Alzheimer's Dis. 21:2 (2010), 577–584.
68. Etminan, M., Gill, S., Samii, A., Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ, 327(7407), 2003, 128.
69. Farina, N., Isaac, M.G., Clark, A.R., Rusted, J., Tabet, N., Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst. Rev., 11, 2012, CD002854.
70. Fei, M., Jianhua, W., Apolipoprotein epsilon4-allele as a significant risk factor for conversion from mild cognitive impairment to Alzheimer's disease: a meta-analysis of prospective studies. J. Mol. Neurosci. 50 (2013), 257–263.
71. Ferreira, P.C., Piai Kde, A., Takayanagui, A.M., Segura-Munoz, S.I., Aluminum as a risk factor for Alzheimer's disease. Rev. Lat. Am. Enfermagem 16:1 (2008), 151–157.
72. Fleminger, S., Oliver, D.L., Lovestone, S., Rabe-Hesketh, S., Giora, A., Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication Journal of Neurology. Neurosurg. Psychiatry 74:7 (2003), 857–862.
73. Folin, M., Baiguera, S., Gallucci, M., Conconi, M.T., Di Liddo, R., Zanardo, A., Parnigotto, P.P., A cross-sectional study of homocysteine-, NO-levels, and CT-findings in Alzheimer dementia, vascular dementia and controls. Biogerontology 6:4 (2005), 255–260.
74. Forti, P., Olivelli, V., Rietti, E., Maltoni, B., Pirazzoli, G., Gatti, R., Gioia, M.G., Ravaglia, G., Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort. Gerontology 58:1 (2012), 41–49.
75. Fotuhi, M., Mohassel, P., Yaffe, K., Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat. Clin. Pract. Neurol. 5:3 (2009), 140–152.
76. Fratiglioni, L., Paillard-Borg, S., Winblad, B., An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 3:6 (2004), 343–353.
77. Friedland, R.P., Fritsch, T., Smyth, K.A., Koss, E., Lerner, A.J., Chen, C.H., Petot, G.J., Debanne, S.M., Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. Proc. Natl. Acad. Sci. U. S. A. 98:6 (2001), 3440–3445.
78. Gao, S., Hendrie, H.C., Hall, K.S., Hui, S., The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch. Gen. Psychiatry 55:9 (1998), 809–815.
79. García, A.M., Sisternas, A., Hoyos, S.P., Occupational exposure to extremely low frequency elective and magnetic fields and Alzheimer disease: a meta-analysis. Int. J. Epidemiol. 37:2 (2008), 329–340.
80. Gates, G.A., Anderson, M.L., McCurry, S.M., Feeney, M.P., Larson, E.B., Central auditory dysfunction as a harbinger of Alzheimer dementia. Arch. Otolaryngol. Head Neck Surg. 137:4 (2011), 390–395.
81. Gauthier, S., Wirth, Y., Mobius, H.J., Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. Int. J. Geriatr. Psychiatry 20:5 (2005), 459–464.
82. Gelber, R.P., Petrovitch, H., Masaki, K.H., Ross, G.W., White, L.R., Coffee intake in midlife and risk of dementia and its neuropathologic correlates. J. Alzheimer's Dis. 23:4 (2011), 607–615.
83. Gelber, R.P., Petrovitch, H., Masaki, K.H., Abbott, R.D., Ross, G.W., Launer, L.J., White, L.R., Lifestyle and the risk of dementia in Japanese-american men. J. Am. Geriatr. Soc. 60:1 (2012), 118–123.
84. Gorospe, E.C., Dave, J.K., The risk of dementia with increased body mass index. Age Ageing 36:1 (2007), 23–29.
85. Graves, A.B., van Duijn, C.M., Chandra, V., Fratiglioni, L., Heyman, A., Jorm, A.F., Kokmen, E., et al. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20:Suppl. 2 (1991), S48–S57.
86. Graves, A.B., van Duijn, C.M., Chandra, V., Fratiglioni, L., Heyman, A., Jorm, A.F., Kokmen, E., et al. Occupational exposures to solvents and lead as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20:Suppl. 2 (1991), S58–S61.
87. Gray, S.L., Walker, R., Dublin, S., Haneuse, S., Crane, P.K., Breitner, J.C., Bowen, J., McCormick, W., Larson, E.B., Histamine-2 receptor agonist use and incident dementia in an older. J. Am. Geriatric Soci. 59:2 (2011), 251–257.
88. Gu, Y., Luchsinger, J.A., Stern, Y., Scarmeas, N., Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease. J. Alzheimer's Dis. 22:2 (2010), 483–492.
89. Gu, Y., Nieves, J.W., Stern, Y., Luchsinger, J.A., Scarmeas, N., Food combination and Alzheimer's disease risk: a protective diet. Arch. Neurol. 67:6 (2010), 699–706.
90. Guan, F., Gu, J., Hu, F., Zhu, Y., Wang, W., Association between alpha1-antichymotrypsin signal peptide −15A/T polymorphism and the risk of Alzheimer's disease: a meta-analysis. Mol. Biol. Rep. 39 (2012), 6661–6669.
91. Guerchet, M., Aboyans, V., Nubukpo, P., Lacroix, P., Clement, J.P., Preux, P.M., Ankle-brachial index as a marker of cognitive impairment and dementia in general population. A systematic review. Atherosclerosis 216:2 (2011), 251–257.
92. Haan, M.N., Miller, J.W., Aiello, A.E., Whitmer, R.A., Jagust, W.J., Mungas, D.M., Allen, L.H., Green, R., Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am. J. Clin. Nutr. 85:2 (2007), 511–517.
93. Hamer, M., Chida, Y., Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol. Med. 39:1 (2009), 3–11.
94. Han, X.M., Wang, C.H., Sima, X., Liu, S.Y., Interleukin-6 −174G/C polymorphism and the risk of Alzheimer's disease in Caucasians: a meta-analysis. Neurosci. Lett. 504:1 (2011), 4–8.
95. Hao, P.P., Chen, Y.G., Wang, J.L., Wang, X.L., Zhang, Y., Meta-analysis of aldehyde dehydrogenase 2 gene polymorphism and Alzheimer's disease in East Asians. Can. J. Neurol. Sci. 38:3 (2011), 500–506.
96. Hao, Z., Wu, B., Wang, D., Liu, M., Association between metabolic syndrome and cognitive decline: a systematic review of prospective population-based studies. Acta Neuropsychiatrica 23:2 (2011), 69–74.
97. Hersi, M., Quach, P., Wang, M.D., Gomes, J., Gaskin, J., Krewski, D., Systematic reviews of factors associated with the onset and progression of neurological conditions in humans: a methodological overview. Neurotoxicology, 2016 (in this issue).
98. Hersi, M., Lifestyle-related Risk Factors for the Onset of Alzheimer's Disease: a Systematic Review of the Literature. 2015 Thesis. University of Ottawa.
99. Heyn, P., Abreu, B.C., Ottenbacher, K.J., The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch. Phys. Med. Rehab. 85:10 (2004), 1694–1704.
100. Higgins, J.P., Flicker, L., Lecithin for dementia and cognitive impairment. Cochrane Database Syst. Rev., 4, 2000, CD001015.
101. Ho, R.C., Cheung, M.W., Fu, E., Win, H.H., Zaw, M.H., Ng, A., Mak, A., Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression. Am. J. Geriatric Psychiatry 19:7 (2011), 607–617.
102. Hogervorst, E., Ribeiro, H.M., Molyneux, A., Budge, M., Smith, A.D., Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (Leukoaraiosis) in patients with Alzheimer disease. Arch. Neurol. 59:5 (2002), 787–793.
103. Hooshmand, B., Solomon, A., Kåreholt, I., Leiviskä, J., Rusanen, M., Ahtiluoto, S., Winblad, B., Laatikainen, T., Soininen, H., Kivipelto, M., Homocysteine and holotranscobalamin and the risk of Alzheimer's disease: a longitudinal study. Neurology 75:16 (2010), 1408–1414.
104. Hua, Y., Zhao, H., Kong, Y., Ye, M., Association between the MTHFR gene and Alzheimer's disease: a meta-analysis. Int. J. Neurosci. 121:8 (2011), 462–471.
105. Hurley, B.F., Hanson, E.D., Sheaff, A.K., Strength training as a countermeasure to aging muscle and chronic disease. Sports Med. 41:4 (2011), 289–306.
106. Isaac, M.G., Quinn, R., Tabet, N., Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst. Rev., 3, 2008, CD002854.
107. Issa, A.M., Mojica, W.A., Morton, S.C., Traina, S., Newberry, S.J., Hilton, L.G., Garland, R.H., Maclean, C.H., The efficacy of omega-3 fatty acids on cognitive function in aging and dementia: a systematic review. Dementia Geriatric Cognit. Disord. 21:2 (2006), 88–96.
108. James, B.D., Boyle, P.A., Buchman, A.S., Barnes, L.L., Bennett, D.A., Life space and risk of Alzheimer's disease, mild cognitive impairment, and cognitive decline in old age. Am. J. Geriatr. Psychiatry 19:11 (2011), 961–969.
109. Joas, E., Backman, K., Gustafson, D., Ostling, S., Waern, M., Guo, X., Skoog, I., Blood pressure trajectories from midlife to late life in relation to dementia in women followed for 37 years. Hypertension 59:4 (2012), 796–801.
110. Jorm, A.F., History of depression as a risk factor for dementia: an updated review. Aust. New Zealand J. Psychiatry 35:6 (2001), 776–781.
111. Keage, H.A., Carare, R.O., Friedland, R.P., Ince, P.G., Love, S., Nicoll, J.A., Wharton, S.B., Weller, R.O., Brayne, C., Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurol., 9, 2009, 3.
112. Kerola, T., Nieminen, T., Hartikainen, S., Sulkava, R., Vuolteenaho, O., Kettunen, R., B-type natriuretic peptide as a predictor of declining cognitive function and dementia −a cohort study of an elderly general population with a 5-year follow-up. Ann. Med. 42:3 (2010), 207–215.
113. Kheifets, L., Bowman, J.D., Checkoway, H., Feychting, M., Harrington, J.M., Kavet, R., Marsh, G., Mezei, G., Renew, D.C., van Wijngaarden, E., Future needs of occupational epidemiology of extremely low frequency electric and magnetic fields: review and recommendations. Occup. Environ. Med. 66:2 (2009), 72–80.
114. Khoury, M.J., Bertram, L., Boffetta, P., Butterworth, A.S., Chanock, S.J., Dolan, S.M., Fortier, I., Carcia-Closas, M., Gwinn, M., et al. Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human disease. Am. J. Epidemiol. 170:3 (2009), 269–279.
115. Kim, J.M., Stewart, R., Kim, S.W., Shin, I.S., Yang, S.J., Shin, H.Y., Yoon, J.S., Changes in folate, vitamin B12 and homocysteine associated with incident dementia. J. Neurol. Neurosurg. Psychiatry 79:8 (2008), 864–868.
116. Kimm, H., Lee, P.H., Shin, Y.J., Park, K.S., Jo, J., Lee, Y., Kang, H.C., Jee, S.H., Midlife and late-life vascular risk factors and dementia in Korean men and women. Arch. Gerontol. Geriatr. 52:3 (2011), e117–e122.
117. Kloppenborg, R.P., van den Berg, E., Kappelle, L.J., Biessels, G.J., Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur. J. Pharmacol. 585:1 (2008), 97–108.
118. Kohler, S., van Boxtel, M., Jolles, J., Verhey, F., Depressive symptoms and risk for dementia: a 9-year follow-up of the Maastricht Aging Study. Am. J. Geriatr. Psychiatry 19:10 (2011), 902–905.
119. Koseoglu, E., Karaman, Y., Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease. Clin. Biochem. 40:12 (2007), 859–863.
120. Koyama, A., O'Brien, J., Weuve, J., Blacker, D., Metti, A.L., Yaffe, K., The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. J. Gerontol. Ser. A-Biol. Sci. Med. Sci. 68 (2013), 433–440.
121. Kristal, A.R., Peters, U., Potter, J.D., Is it time to abandon the food frequency questionnaire?. Cancer Epidemiol. Biomarkers Prevention 14:12 (2005), 2826–2828.
122. Kuo, H.K., Sorond, F.A., Chen, J.H., Hashmi, A., Milberg, W.P., Lipsitz, L.A., The role of homocysteine in multisystem age-related problems: a systematic review. J. Gerontol. Ser. A-Biol. Sci. Med. Sci. 60:9 (2005), 1190–1201.
123. Kuo, H.K., Yen, C.J., Chang, C.H., Kuo, C.K., Chen, J.H., Sorond, F., Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol. 4:6 (2005), 371–380.
124. LaRoia, H., Louis, E.D., Association between essential tremor and other neurodegenerative diseases: what is the epidemiological evidence?. Neuroepidemiology 37:1 (2011), 1–10.
125. LeBlanc, E.S., Janowsky, J., Chan, B.K., Nelson, H.D., Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 285:11 (2001), 1489–1499.
126. Lee, Y., Back, J.H., Kim, J., Kim, S.H., Na, D.L., Cheong, H.K., Hong, C.H., Kim, Y.G., Systematic review of health behavioral risks and cognitive health in older adults. Int. Psychogeriatr. 22:2 (2010), 174–187.
127. Leinonen, V., Koivisto, A.M., Savolainen, S., Rummukainen, J., Tamminen, J.N., Tillgren, T., Vainikka, S., et al. Amyloid and (proteins in cortical brain biopsy and Alzheimer's disease. Ann. Neurol. 68:4 (2010), 446–453.
128. Lenoir, H., Dufouil, C., Auriacombe, S., Lacombe, J.M., Dartigues, J.F., Ritchie, K., Tzourio, C., Depression history, depressive symptoms, and incident dementia: the 3C Study. J. Alzheimer's Dis. 26:1 (2011), 27–38.
129. Li, G., Shofer, J.B., Rhew, I.C., Kukull, W.A., Peskind, E.R., McCormick, W., Bowen, J.D., et al. Age-varying association between statin use and incident Alzheimer's disease. J. Am. Geriatr. Soc. 58:7 (2010), 1311–1317.
130. Li, N.C., Lee, A., Whitmer, R.A., Kivipelto, M., Lawler, E., Kazis, L.E., Wolozin, B., Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ, 340, 2010, b5465.
131. Li, G., Wang, L.Y., Shofer, J.B., Thompson, M.L., Peskind, E.R., McCormick, W., Bowen, J.D., Crane, P.K., Larson, E.B., Temporal relationship between depression and dementia: findings from a large community-based 15-year follow-up study. Arch. Gen. Psychiatry 68:9 (2011), 970–977.
132. Li, F.J., Shen, L., Ji, H.F., Dietary intakes of vitamin E, vitamin C, and beta-carotene and risk of Alzheimer's disease: a meta-analysis. J. Alzheimer's Dis. 31 (2012), 253–258.
133. Lim, W.S., Gammack, J.K., Van Niekerk, J.K., Dangour, A., Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst. Rev., 1, 2006, CD005379.
134. Lin, F.R., Metter, E.J., O'Brien, R.J., Resnick, S.M., Zonderman, A.B., Ferrucci, L., Hearing loss and incident dementia. Arch. Neurol. 68:2 (2011), 214–220.
135. Lin, M., Zhao, L., Fan, J., Lian, X.G., Ye, J.X., Wu, L., et al. Association between HFE polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis of 22 studies including 4,365 cases and 8,652 controls. Mol. Biol. Rep. 39 (2012), 3089–3095.
136. Lin, Y., Cheng, S., Xie, Z., Zhang, D., Association of rs6265 and rs2030324 polymorphisms in brain-derived neurotrophic factor gene with Alzheimer's disease: a meta-analysis. PLoS One [Electron. Resour.], 9, 2014, e94961.
137. Lindsay, J., Anderson, L., Dementia and Alzheimer's Disease. Women's Health Surveillance Report., 2003, Public Health Agency of Canada http://www.phac-aspc.gc.ca/publicat/whsr-rssf/chap_19-eng.php.
138. Lipton, R.B., Hirsch, J., Katz, M.J., Wang, C., Sanders, A.E., Verghese, J., Barzilai, N., Derby, C.A., Exceptional parental longevity associated with lower risk of Alzheimer's disease and memory decline. J. Am. Geriatr. Soc. 58:6 (2010), 1043–1049.
139. Littbrand, H., Stenvall, M., Rosendahl, E., Applicability and effects of physical exercise on physical and cognitive functions and activities of daily living among people with dementia: a systematic review. Am. J. Phys. Med. Rehab. 90:6 (2011), 495–518.
140. Liu, Y., Zhang, J., Zeng, Z., Vascular endothelial growth factor polymorphisms and risk of Alzheimer's disease: a meta-analysis. Gene 518 (2013), 296–302.
141. Liu, M., Bian, C., Zhang, J., Wen, F., Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis. Sci. Rep., 4, 2014, 4383.
142. Llorca, J., Rodriguez-Rodriguez, E., Dierssen-Sotos, T., Delgado-Rodriguez, M., Berciano, J., Combarros, O., Meta-analysis of genetic variability in the beta-amyloid production, aggregation and degradation metabolic pathways and the risk of Alzheimer's disease. Acta Neurol. Scand. 117:1 (2008), 1–14.
143. Loef, M., Walach, H., Copper and iron in Alzheimer's disease: a systematic review and its dietary implications. Br. J. Nutr. 107:1 (2012), 7–19.
144. Loef, M., Walach, H., Fruit, vegetables and prevention of cognitive decline or dementia: a systematic review of cohort studies. J. Nutr. Health Aging 16:7 (2012), 626–630.
145. Loef, M., Mendoza, L.F., Walach, H., Lead (Pb) and the risk of Alzheimer's disease or cognitive decline: a systematic review. Tox. Rev. 30:4 (2011), 103–114.
146. Loef, M., Schrauzer, G.N., Walach, H., Selenium and Alzheimer's disease: a systematic review. J. Alzheimer's Dis. 26:1 (2011), 81–104.
147. Loef, M., von Stillfried, N., Walach, H., Zinc diet and Alzheimer's disease: a systematic review. Nutr. Neurosci. 15:5 (2012), 2–12.
148. Lopez, L.B., Kritz-Silverstein, D., Barrett Connor, E., High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study. J. Nutr. Health Aging 15:1 (2011), 25–31.
149. Louis, E.D., Tang, M.X., Schupf, N., Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population-based study of elders. Mov. Disord. 25:2 (2010), 172–178.
150. Lourida, I., Soni, M., Thompson-Coon, J., Purandare, N., Lang, I.A., Ukoumunne, O.C., et al. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology 24 (2013), 479–489.
151. Lu, F.P., Lin, K.P., Kuo, H.K., Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS ONE [Electron. Resour.], 4(1), 2009, e4144.
152. Lu, Y., et al. Quantitative assessment of CYP2D6 polymorphisms and risk of Alzheimer's disease: a meta-analysis. J. Neurol. Sci. 343 (2014), 15–22.
153. Luchsinger, J.A., Tang, M.X., Shea, S., Miller, J., Green, R., Mayeux, R., Plasma homocysteine levels and risk of Alzheimer disease. Neurology 62:11 (2004), 1972–1976.
154. Luo, J., Li, S., Qin, X., Song, L., Peng, Q., Chen, S., et al. Meta-analysis of the association between CR1 polymorphisms and risk of late-onset Alzheimer's disease. Neurosci. Lett. 578 (2014), 165–170.
155. Macedo, A.F., Taylor, F.C., Casas, J.P., Adler, A., Prieto-Merino, D., Ebrahim, S., Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis. BMC Med., 12, 2014, 51.
156. Malouf, R., Areosa Sastre, A., Vitamin B12 for cognition. Cochrane Database Syst. Rev., 3, 2003, CD004326.
157. Malouf, R., Grimley, E.J., Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst. Rev., 4, 2008, CD004514.
158. Malouf, M., Grimley, E.J., Areosa, S.A., Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst. Rev., 4, 2003, CD004514.
159. Marengoni, A., Qiu, C., Winblad, B., Fratiglioni, L., Atrial fibrillation, stroke and dementia in the very old: a population-based study. Neurobiol. Aging 32:7 (2011), 1336–1337.
160. McGuinness, B., Todd, S., Passmore, P., Bullock, R., Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst. Rev., 4, 2009, CD004034.
161. Meng, X., D'Arcy, C., Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS ONE [Electron. Resour.], 7(6), 2012, e38268.
162. Mielke, M.M., Zandi, P.P., Shao, H., Waern, M., Ostling, S., Guo, X., Bjorkelund, C., Lissner, L., Skoog, I., Gustafson, D.R., The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology 75:21 (2010), 1888–1895.
163. Miller, L.J., Chacko, R., The role of cholesterol and statins in Alzheimer's disease. Ann. Pharmacother. 38:1 (2004), 91–98.
164. Miller, J.W., Green, R., Mungas, D.M., Reed, B.R., Jagust, W.J., Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology 58:10 (2002), 1471–1475.
165. Mitchell, A.J., Shiri-Feshki, M., Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis Journal of Neurology. Neurosurg. Psychiatry 79:12 (2008), 1386–1391.
166. Mitchell, A.J., Shiri-Feshki, M., Rate of progression of mild cognitive impairment to dementia–meta-analysis of 41 robust inception cohort studies. Acta Psychiatr. Scand. 119:4 (2009), 252–265.
167. Mo, C., Peng, Q., Sui, J., Wang, J., Deng, Y., Xie, L., et al. Lack of association between cathepsin D C224T polymorphism and Alzheimer's disease risk: an update meta-analysis. BMC Neurol., 14, 2014, 13.
168. Montlahuc, C., Soumare, A., Dufouil, C., Berr, C., Dartigues, J.F., Poncet, M., Tzourio, C., Alperovitch, A., Self-rated health and risk of incident dementia: a community-based elderly cohort, the 3C study. Neurology 77:15 (2011), 1457–1464.
169. Mortimer, J.A., van Duijn, C.M., Chandra, V., Fratiglioni, L., Graves, A.B., Heyman, A., Jorm, A.F., et al. Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20:Suppl.2 (1991), S28–S35.
170. Muller, M., Schupf, N., Manly, J.J., Mayeux, R., Luchsinger, J.A., Sex hormone binding globulin and incident Alzheimer's disease in elderly men and women. Neurobiol. Aging 31:10 (2010), 1758–1765.
171. Nägga, K., Rajani, R., Mårdh, E., Borch, K., Mårdh, S., Marcusson, J., Cobalamin, folate, methylmalonic acid, homocysteine, and gastritis markers in dementia. Dement. Geriatr. Cogn. Disord. 16:4 (2003), 269–275.
172. National Advisory Council on Aging (Canada), The NACA Position on Alzheimer Disease and Related Dementias. 2004 http://books2. scholarsportal.info/viewdoc.html?id=/ebooks/ebooks1/gibson_chrc/2010-08-06/1/10089389.
173. Ning, M., Yang, Y., Zhang, Z., Chen, Z., Zhao, T., Zhang, D., Zhou, D., Xu, J., Liu, Z., Wang, Y., Liu, Y., Zhao, X., Li, W., Li, S., He, L., Amyloid-β-Related genes SORL1 and ACE are genetically associated with risk for late-onset alzheimer disease in the chinese population. Alzheimer Dis. Relat. Disord. 24:4 (2010), 390–396.
174. Norton, M.C., Dew, J., Smith, H., Fauth, E., Piercy, K.W., Breitner, J.C., Tschanz, J., Wengreen, H., Welsh-Bohmer, K., Cache County Investigators, Lifestyle behavior pattern is associated with different levels of risk for incident dementia and Alzheimer's disease: the Cache County study. J. Am. Geriatr. Soc. 60:3 (2012), 405–412.
175. Ntais, C., Polycarpou, A., Ioannidis, J.P., Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease: a HuGE gene-disease association review. Am. J. Epidemiol. 159:6 (2004), 527–536.
176. O'Brien, J., Jackson, J.W., Grodstein, F., Blacker, D., Weuve, J., Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease. Epidemiol. Rev. 36 (2014), 83–103.
177. O'Leary, F., Allman-Farinelli, M., Samman, S., Vitamin B12 status: cognitive decline and dementia: a systematic review of prospective cohort studies. Br. J. Nutr. 108 (2012), 1948–1961.
178. Ohara, T., Doi, Y., Ninomiya, T., Hirakawa, Y., Hata, J., Iwaki, T., Kanba, S., Kiyohara, Y., Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology 77:12 (2011), 1126–1134.
179. Ownby, R.L., Crocco, E., Acevedo, A., John, V., Loewenstein, D., Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch. Gen. Psychiatry 63:5 (2006), 530–538.
180. Pan, Y., Li, Y., Shen, H., Meta-analysis of the association between polymorphisms of estrogen receptor alpha genes rs9340799 and rs2234693 and Alzheimer's disease: evidence from 23 articles. Am. J. Alzheimer's Dis. Other Dementias 29 (2014), 704–711.
181. Paradise, M., Cooper, C., Livingston, G., Systematic review of the effect of education on survival in Alzheimer's disease. Int. Psychogeriatr. 21:1 (2009), 25–32.
182. Parihar, M.S., Hemnani, T., Alzheimer's disease pathogenesis and therapeutic interventions. J. Clin. Neurosci. 11:5 (2004), 456–467.
183. Patatanian, E., Gales, M.A., The future of statins: alzheimer's disease?. Consult. Pharm. 20:8 (2005), 663–673.
184. Patterson, C., Feightner, J., Garcia, A., MacKnight, C., General risk factors for dementia: a systematic evidence review. Alzheimer's Dementia 3:4 (2007), 341–347.
185. Penrose, F.K., Can exercise affect cognitive functioning in Alzheimer ‘s disease? A review of the literature. Activities Adaptation Aging 29:4 (2005), 15–40.
186. Peters, R., Burch, L., Warner, J., Beckett, N., Poulter, R., Bulpitt, C., Haemoglobin, anaemia, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr., 8, 2008, 18.
187. Peters, R., Peters, J., Warner, J., Beckett, N., Bulpitt, C., Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 37:5 (2008), 505–512.
188. Peters, R., Poulter, R., Warner, J., Beckett, N., Burch, L., Bulpitt, C., Smoking, dementia, and cognitive decline in the elderly, a systematic review. BMC Geriatr., 8, 2008, 36.
189. Pham, D.Q., Plakogiannis, R., Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: part 2. Ann. Pharmacother. 39:12 (2005), 2065–2072.
190. Pitner, J.K., Obesity in the elderly. Consult. Pharm. 20:6 (2005), 498–513.
191. Podewils, L.J., Physical Activity and Dementia Risk: a Systematic Review. 2003 (Diss., Johns Hopkins University).
192. Power, M.C., Weuve, J., Gagne, J.J., McQueen, M.B., Viswanathan, A., Blacker, D., The association between blood pressure and incident alzheimer disease: a systematic review and meta-analysis. Epidemiology 22:5 (2011), 646–659.
193. Profenno, L.A., Porsteinsson, A.P., Faraone, S.V., Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol. Psychiatry 67:6 (2010), 505–512.
194. Psaltopoulou, T., Sergentanis, T.N., Panagiotakos, D.B., Sergentanis, I.N., Kosti, R., Scarmeas, N., Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann. Neurol. 74 (2013), 580–591.
195. Public Health Agency of Canada, Chapter 3: The Health and Well-being of Canadian Seniors. The Chief Public Health Officer's Report on The State of Public Health in Canada 2010., 2010 Accessed 28 Oct. 2013 http://www.phac-aspc.gc.ca/cphorsphc-respcacsp/2010/fr-rc/cphorsphc-respcacsp-06-eng.php.
196. Purnell, C., Callahan, C.M., Hendrie, H.C., Cardiovascular risk factors and incident alzheimer's disease: a systematic review of the literature. Alzheimer Dis. Assoc. Disord. 23:1 (2009), 1–10.
197. Qin, X., Peng, Q., Zeng, Z., Chen, Z., Lin, L., Deng, Y., et al. Interleukin-1A −889C/T polymorphism and risk of Alzheimer's disease: a meta-analysis based on 32 case-control studies. J. Neurol. 259 (2012), 1519–1529.
198. Qiu, C., Xu, W., Winblad, B., Fratiglioni, L., Vascular risk profiles for dementia and Alzheimer's disease in very old people: a population-based longitudinal study. J. Alzheimer's Dis. 20:1 (2010), 293–300.
199. Quadri, P., Fragiacomo, C., Pezzati, R., Zanda, E., Forloni, G., Tettamanti, M., Lucca, U., Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr. 80:1 (2004), 114–122.
200. Rainero, I., Bo, M., Ferrero, M., Valfrè, W., Vaula, G., Pinessi, L., Association between the interleukin-1α gene and Alzheimer's disease: a meta-analysis. Neurobiol. Aging 25:10 (2004), 1293–1298.
201. Raman, G., Tatsioni, A., Chung, M., Rosenberg, I.H., Lau, J., Lichtenstein, A.H., Balk, E.M., Heterogeneity and lack of good quality studies limit association between folate, vitamins B-6 ad B-12, and cognitive function. J. Nutr. 137:7 (2007), 1789–1794.
202. Raschetti, R., Albanese, E., Vanacore, N., Maggini, M., Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials. PLoS Med. Public Lib. Sci., 4(11), 2007, e338.
203. Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., Porcellini, E., Licastro, F., Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am. J. Clin. Nutr. 82:3 (2005), 636–643.
204. Reitz, C., Tang, M.X., Schupf, N., Manly, J.J., Mayeux, R., Luchsinger, J.A., Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch. Neurol. 67:12 (2010), 1491–1497.
205. Reitz, C., Tang, M.X., Schupf, N., Manly, J.J., Mayeux, R., Luchsinger, J.A., b: a summary risk score for the prediction of Alzheimer disease in elderly persons. Arch. Neurol. 67:7 (2010), 835–841.
206. Reitz, C., Cheng, R., Rogaeva, E., Lee, J.H., Tokuhiro, S., Zou, F., Bettens, K., et al. Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch. Neurol. 68:1 (2011), 99–106.
207. Religa, D., Styczynska, M., Peplonska, B., Gabryelewicz, T., Pfeffer, A., Chodakowska, M., Luczywek, E., Wasiak, B., Stepien, K., Golebiowski, M., Winblad, B., Barcikowska, M., et al. Homocysteine, apolopoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 16:2 (2003), 4–70.
208. Reutens, S., Sachdev, P., Homocysteine in neuropsychiatric disorders of the elderly. Int. J. Geriatr. Psychiatry 17:9 (2002), 859–864.
209. Rocca, W.A., van Duijn, C.M., Clayton, D., Chandra, V., Fratiglioni, L., Graves, A.B., Heyman, A., et al. Maternal age and Alzheimer's disease: a collaborative re-analysis of case-control studies: EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20:Suppl. 2 (1991), S21–7.
210. Rodriguez-Manotas, M., Amorin-Diaz, M., Canizares-Hernandez, F., Ruiz-Espejo, F., Martinez-Vidal, S., Gonzalez-Sarmiento, R., Martinez-Hernandez, P., Cabezas-Herrera, J., Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism. Brain Res. 1170 (2007), 119–128.
211. Roe, C.M., Fitzpatrick, A.L., Xiong, C., Sieh, W., Kuller, L., Miller, J.P., Williams, M.M., Kopan, R., Behrens, M.I., Morris, J.C., Cancer linked to Alzheimer disease but not vascular dementia. Neurology 74:2 (2010), 106–112.
212. Rolland, Y., Abellan van Kan, G., Vellas, B., Physical activity and Alzheimer's disease: from prevention to therapeutic perspectives. J. Am. Med. Dir. Assoc. 9:6 (2008), 390–405.
213. Roman, B., Carta, L., Martinez-Gonzalez, M.A., Serra-Majem, L., Effectiveness of the Mediterranean diet in the elderly. Clin. Interv. Aging 3:1 (2008), 97–109.
214. Ronnemaa, E., Zethelius, B., Lannfelt, L., Kilander, L., Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dementia Geriatric Cognit. Disord. 31:6 (2011), 460–466.
215. Rusanen, M., Kivipelto, M., Quesenberry, C.P.Jr., Zhou, J., Whitmer, R.A., Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch. Intern. Med. 171:4 (2011), 333–339.
216. Saczynski, J.S., Beiser, A., Seshadri, S., Auerbach, S., Wolf, P.A., Au, R., Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology 75:1 (2010), 35–41.
217. Santibanez, M., Bolumar, F., Garcia, A.M., Occupational risk factors in Alzheimer's disease: a review assessing the quality of published epidemiological studies. Occup. Environ. Med. 64:11 (2007), 723–732.
218. Santos, C., Costa, J., Santos, J., Vaz-Carneiro, A., Lunet, N., Caffeine intake and dementia: systematic review and meta-analysis. J. Alzheimer's Dis. 20:Suppl 1 (2010), S187–204.
219. Schrijvers, E.M., Witteman, J.C., Sijbrands, E.J., Hofman, A., Koudstaal, P.J., Breteler, M.M., Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study. Neurology 75:22 (2010), 1982–1987.
220. Schrijvers, E.M., Koudstaal, P.J., Hofman, A., Breteler, M.M., et al. Plasma clusterin and the risk of Alzheimer disease. J. Am. Med. Assoc. 305:13 (2011), 1322–1326.
221. Seshadri, S., Beiser, A., Selhub, J., Jacques, P.F., Rosenberg, I.H., D'Agostino, R.B., Wilson, P.W., Wolf, P.A., Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New Engl. J. Med. 346:7 (2002), 476–483.
222. Shadlen, M.F., Larson, E.B., Yukawa, M., The epidemiology of Alzheimer's disease and vascular dementia in Japanese and African-American populations: the search for etiological clues. Neurobiol. Aging 21:2 (2000), 171–181.
223. Shah, K., Qureshi, S.U., Johnson, M., Parikh, N., Schulz, P.E., Kunik, M.E., Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review. Am. J. Geriatr. Pharmacother. 7:5 (2009), 250–261.
224. Shah, R.C., Buchman, A.S., Wilson, R.S., Leurgans, S.E., Bennett, D.A., Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis. Neurology 77:3 (2011), 219–226.
225. Shah, N.S., Vidal, J.S., Masaki, K., Petrovitch, H., Ross, G.W., Tilley, C., DeMattos, R.B., Tracy, R.P., White, L.R., Launer, L.J., Midlife blood pressure, plasma β-Amyloid and the risk for alzheimer's disease: the Honolulu asia aging study. Hypertension 59:4 (2012), 780–786.
226. Shea, B.J., Hamel, C., Wells, G.A., Bouter, L.M., Kristjansson, E., Grimshaw, J., Henry, D.A., Boers, M., AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J. Clin. Epidemiol. 62 (2009), 1013–1020.
227. Singh, B., Parsaik, A.K., Mielke, M.M., Erwin, P.J., Knopman, D.S., Petersen, R.C., et al. Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review ad meta-analysis. J. Alzheimer's Dis. 39 (2014), 271–282.
228. Sofi, F., Cesari, F., Abbate, R., Gensini, G.F., Casini, A., Adherence to Mediterranean diet and health status: meta-analysis. BMJ, 337, 2008, a1344.
229. Sofi, F., Abbate, R., Gensini, G.F., Casini, A., Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am. J. Clin. Nutr. 92:5 (2010), 1189–1196.
230. Song, X., Mitnitski, A., Rockwood, K., Nontraditional risk factors predict Alzheimer disease. Neurology 77:3 (2011), 227–234.
231. Song, Y., Nie, H., Xu, Y., Zhang, L., Wu, Y., Association of statin use with risk of dementia: a meta-analysis of prospective cohort studies. Geriatrics Gerontol. Int. 13 (2013), 817–824.
232. Standridge, J.B., Pharmacotherapeutic approaches to the prevention of Alzheimer's disease. Am. J. Geriatr. Pharmacother. 2:2 (2004), 119–132.
233. Stern, C., Konno, R., Physical leisure activities and their role in preventing dementia: a systematic review. Int. J. Evide. Based Healthcare 7:4 (2009), 270–282.
234. Stern, C., Munn, Z., Cognitive leisure activities and their role in preventing dementia: a systematic review. Inte. J. Evid. Based Healthcare 8:1 (2010), 2–17.
235. Stern, Y., Cognitive reserve and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 20:3 (Sulppl. 2) (2006), S69–S74.
236. Storey, S.G., Suryadevara, V., Aronow, W.S., Ahn, C., Association of plasma homocysteine in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascular disease. J. Gerontol. 58:12 (2003), 1135–1136.
237. Sundelöf, J., Sundström, J., Hansson, O., Eriksdotter-Jönhagen, M., Giedraitis, V., Larsson, A., Degerman-Gunnarsson, M., Ingelsson, M., Minthon, L., Blennow, K., Kilander, L., Basun, H., Lannfelt, L., Cystatin C levels are positively correlated with Aβ42 and τ levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls. J. Alzheimer's Dis. 21:2 (2012), 471–478.
238. Szekely, C.A., Thorne, J.E., Zandi, P.P., Ek, M., Messias, E., Breitner, J.C., Goodman, S.N., Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 23:4 (2004), 159–169.
239. Verdelho, A., Madureira, S., Moleiro, C., Ferro, J.M., Santos, C.O., Erkinjuntti, T., Pantoni, L., et al. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 75:2 (2010), 160–167.
240. Vergara, X., Kheifets, L., Greenland, S., Oksuzyan, S., Cho, Y.S., Mezei, G., Occupational exposure to extremely low-frequency magnetic fields and neurodegenerative disease: a meta-analysis. J. Occup. Environ. Med. 55 (2013), 135–146.
241. Wang, Y., Bi, L., Wang, H., Li, Y., Di, Q., Xu, W., et al. NEDD9 rs760678 polymorphism and the risk of Alzheimer's disease: a meta-analysis. Neurosci. Lett. 527 (2012), 121–125.
242. Wang, X.F., Cao, Y.W., Feng, Z.Z., Fu, D., Ma, Y.S., Zhang, F., et al. Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer's disease. Mol. Biol. Rep. 40 (2013), 779–785.
243. Wang, Y., Xu, S., Liu, Z., Lai, C., Xie, Z., Zhao, C., et al. Meta-analysis on the association between the TF gene rs1049296 and AD. Can. J. Neurol. Sci. 40:5 (2013), 691–697.
244. Wang, C., Yu, J.T., Wang, H.F., Jiang, T., Tan, C.C., Meng, X.F., et al. Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer's disease. PLoS ONE [Electron. Resour.], 9, 2014, e89041.
245. Wang, J., Tan, L., Wang, H.F., Tan, C.C., Meng, X.F., Wang, C., et al. Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis. J. Alzheimer's Dis. 44 (2015), 385–396.
246. Wang, X.B., Cui, N.H., Gao, J.J., Qiu, X.P., Yang, N., Zheng, F., Angiotensin-converting enzyme gene polymorphisms and risk for sporadic Alzheimer's disease: a meta-analysis. J. Neural Transm. 122 (2015), 211–224.
247. Wang, T., Meta-analysis of PvuII: XbaI variants in ESR1 gene and the risk of Alzheimer's disease: the regional European difference. Neurosci. Lett. 574 (2014), 41–46.
248. Wang, T., TNF-alpha G308A polymorphism and the susceptibility to Alzheimer's disease: an updated meta-analysis. Arch. Med. Res. 46 (2015), 24–30 (e1).
249. Weih, M., Wiltfang, J., Kornhuber, J., Non-pharmacologic prevention of Alzheimer's disease: nutritional and life-style risk factors. J. Neural Transm. 114:9 (2007), 1187–1197.
250. Weih, M., Degirmenci, Ü., Kreil, S., Kornhuber, J., Physical activity and Alzheimer's disease: a meta-analysis of cohort studies. GeroPsych 23:1 (2010), 17–20.
251. Weyerer, S., Schaufele, M., Wiese, B., Maier, W., Tebarth, F., van den Bussche, H., Pentzek, M., et al. Current alcohol consumption and its relationship to incident dementia: results from a 3-year follow-up study among primary care attenders aged 75 years and older. Age Ageing 40:4 (2011), 456–463.
252. Williams, J.W., Plassman, B.L., Burke, J., Benjamin, S., Preventing Alzheimer's Disease and Cognitive Decline. Evidence Report/Technology Assessment N0. 193. (Prepared by the Duke Evidence-based Practice Center Under Contract No. HHSA 290–2007-10066-I.) AHRQ Publication No. 10-E005., 2010, Agency for Healthcare Research and Quality, Rockville, MD.
253. Wong, W.B., Lin, V.W., Boudreau, D., Devine, E.B., Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding. Pharmacoepidemiol. Drug Saf. 22 (2013), 345–358.
254. Woods, B., Aguirre, E., Spector, A.E., Orrell, M., Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst. Rev., 2, 2012, CD005562.
255. Wu, W., Jiang, H., Wang, M., Zhang, D., Meta-analysis of the association between urokinase-plasminogen activator gene rs2227564 polymorphism and Alzheimer's disease. Am. J. Alzheimer's Dis. Other Dementias 28 (2013), 517–523.
256. Wu, S., Ding, Y., Wu, F., Li, R., Hou, J., Mao, P., Omega-3 fatty acids intake and risks of dementia and Alzheimer's disease: a meta-analysis. Neurosci. Biobehav. Rev. 48 (2015), 1–9.
257. Xin, X.Y., Ding, J.Q., Chen, S.D., Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis. J. Alzheimer's Dis. 19:4 (2010), 1283–1294.
258. Xu, W.L., Atti, A.R., Gatz, M., Pedersen, N.L., Johansson, B., Fratiglioni, L., Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology 76:18 (2011), 1568–1574.
259. Yaffe, K., Sawaya, G., Lieberburg, I., Grady, D., Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279:9 (1998), 688–695.
260. Yang, Y.H., Roe, C.M., Morris, J.C., Relationship between late-life hypertension, blood pressure, and Alzheimer's disease. Am. J. Alzheimer's Dis. Other Dementias 26:6 (2011), 457–462.
261. Yang, Z.D., Yu, J., Zhang, Q., Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: a systematic review of randomized controlled trials. Maturitas 75 (2013), 341–348.
262. Zhang, T., Jia, Y., Meta-analysis of Ubiquilin1 gene polymorphism and Alzheimer's disease risk. Med. Sci. Monit. 20 (2014), 2250–2255.
263. Zhang, M.Y., Miao, L., Li, Y.S., Hu, G.Y., Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to Alzheimer's disease. Neurosci. Res. 68:2 (2010), 142–150.
264. Zhang, Y., Zhang, J., Tian, C., Xiao, Y., Li, X., He, C., Huang, J., Fan, H., The −1082G/A polymorphism in IL-10 gene is associated with risk of Alzheimer's disease: a meta-analysis. J. Neurol. Sci. 303:1-2 (2011), 133–138.
265. Zhong, G., Wang, Y., Zhang, Y., Guo, J.J., Zhao, Y., Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLoS ONE [Electron. Resour.], 10, 2015, e0118333.
266. Zhou, B., Teramukai, S., Fukushima, M., Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis. Dementia Geriatric Cognit. Disord. 23:3 (2007), 194–201.
267. Zhou, R., Deng, J., Zhang, M., Zhou, H.D., Wang, Y.J., Association between bone mineral density and the risk of Alzheimer's disease. J. Alzheimer's Dis. 24:1 (2011), 101–108.
268. Zhou, Q., Zhao, F., Lv, Z.P., Zheng, C.G., Zheng, W.D., Sun, L., et al. Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis. PLoS ONE [Electron. Resour.], 9, 2014, e87017.
269. Zuo, C., Zuo, Z., Spine Surgery under general anesthesia may not increase the risk of Alzheimer's disease. Dementia Geriatric Cognit. Disord. 29:3 (2010), 233–239.
270. de Craen, A.J., Gussekloo, J., Vrijsen, B., Westendorp, R.G., Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia. Am. J. Epidemiol. 161:2 (2005), 114–120.
271. de Jong, F.J., Schrijvers, E.M., Ikram, M.K., Koudstaal, P.J., de Jong, P.T., Hofman, A., Vingerling, J.R., Breteler, M.M., Retinal vascular caliber and risk of dementia: the Rotterdam study. Neurology 76:9 (2011), 816–821.
272. van Duijn, C.M., Clayton, D., Chandra, V., Fratiglioni, L., Graves, A.B., Heyman, A., Jorm, A.F., et al. Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20:Suppl. 2 (1991), S13–S20.